We observed downregulation of adiponectin/t-cadherin in the 5.5CG that was, in turn, associated with cardiac hypertrophy, poor LV performance, and signs of impaired muscle contractility. The gene discussed is ADIPOQ; the disease is cardiac hypertrophy.